Loading clinical trials...
Loading clinical trials...
A Phase III, Open-label, Randomized Parallel-group Study on the Immunogenicity and Safety of Quinvaxem® DTwP-HepB-Hib) in Uniject™ With Quinvaxem® Monodose Vials in Healthy Infants at 6, 10 and 14 Weeks of Age
Conditions
Interventions
Quinvaxem in Uniject
Quinvaxem in single dose vials
Locations
1
Philippines
Research Institute for Tropical Medicine
City of Muntinlupa, Philippines
Start Date
September 1, 2013
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
July 15, 2014
NCT07203755
NCT07112144
NCT06947499
NCT06803524
NCT07149454
NCT06258057
Lead Sponsor
Crucell Holland BV
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions